Literature DB >> 22356625

Haemolytic uremic syndrome and gemcitabine: jaundice is not always progression in cholangiocarcinoma.

Laurence Crouzet, Julien Edeline, Fanny Le Du, Eveline Boucher, Odile Audrain, Jean-Luc Raoul.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22356625     DOI： 10.3109/0284186X.2012.661073

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  3 in total

1.  Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort.

Authors:  Florence Daviet; Franck Rouby; Pascale Poullin; Julie Moussi-Francès; Marion Sallée; Stéphane Burtey; Julien Mancini; Florence Duffaud; Renaud Sabatier; Bertrand Pourroy; Aurélie Grandvuillemin; Steven Grange; Véronique Frémeaux-Bacchi; Paul Coppo; Joëlle Micallef; Noémie Jourde-Chiche
Journal:  Br J Clin Pharmacol       Date:  2018-12-18       Impact factor: 4.335

Review 2.  Drug-induced thrombotic microangiopathy: a systematic review of published reports.

Authors:  Zayd L Al-Nouri; Jessica A Reese; Deirdra R Terrell; Sara K Vesely; James N George
Journal:  Blood       Date:  2014-11-20       Impact factor: 22.113

3.  An Update in Drug-Induced Thrombotic Microangiopathy.

Authors:  Thomas Chatzikonstantinou; Maria Gavriilaki; Achilles Anagnostopoulos; Eleni Gavriilaki
Journal:  Front Med (Lausanne)       Date:  2020-05-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.